Thyroid hormone replacement therapy

This page covers all Thyroid hormone replacement therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Thyroid hormone receptors (TR-alpha and TR-beta), Thyroid hormone receptors (TR-alpha, TR-beta), Thyroid hormone receptor.

Targets

Thyroid hormone receptors (TR-alpha and TR-beta) · Thyroid hormone receptors (TR-alpha, TR-beta) · Thyroid hormone receptor

Marketed (3)

• Levothyroxine-Na + iodide · Sanofi · Endocrinology
  Levothyroxine-Na replaces deficient thyroid hormone to restore normal metabolic function, while iodide provides substrate for thyroid hormone synthesis.
• Armour Thyroid · AbbVie · Endocrinology
  Armour Thyroid replaces deficient thyroid hormones by providing a combination of T4 (levothyroxine) and T3 (liothyronine) derived from desiccated porcine thyroid tissue.
• L-T4+T3 (thyroid tablet) · Zhongshan Hospital Xiamen University · Endocrinology
  L-T4+T3 combination therapy replaces deficient thyroid hormones by providing both levothyroxine (T4) and liothyronine (T3) to restore normal thyroid hormone levels.

Phase 3 pipeline (1)

• TT3-LITE Regimen (L-TT3) · University of Arkansas · Endocrinology
  L-TT3 is a thyroid hormone replacement therapy that mimics the natural thyroid hormone, T3.